Related Experiment Video
Updated: Nov 2, 2025

04:22
Application of Laparoscopic Hepatectomy Combined with Intraoperative Microwave Ablation in Colorectal Cancer Liver Metastasis
Published on: March 3, 2023
624
Precision Breast-Conserving Surgery With Microwave Ablation Guidance: A Pilot Single-Center, Prospective Cohort
Hong Pan1,2, Mengjia Qian1,2, Hao Chen1,2
1Department of Breast Surgery, The First Affiliated Hospital with Nanjing Medical University, Nanjing, China.
Frontiers in Oncology
|June 14, 2021
Summary
Preoperative microwave ablation (MWA) can guide breast-conserving surgery (BCS) for early-stage breast cancer, reducing positive margins and improving surgical accuracy without affecting sentinel lymph node biopsy outcomes.
Area of Science:
- Oncology
- Surgical Oncology
- Medical Imaging
Background:
- Achieving negative margins in breast-conserving surgery (BCS) is critical for preventing cancer recurrence.
- Early-stage breast cancer management often involves BCS to preserve breast tissue.
- The effectiveness of preoperative techniques in improving BCS outcomes requires further investigation.
Purpose of the Study:
- To evaluate the utility of preoperative microwave ablation (MWA) in guiding BCS for early-stage breast cancer.
- To determine if MWA influences the rates of positive resection margins during BCS.
- To assess the impact of MWA on the accuracy of BCS and sentinel lymph node biopsy (SLNB).
Main Methods:
- A prospective study involving 22 women with T1/T2 invasive breast cancer from 2016-2018.
- Ultrasound-guided MWA performed under local anesthesia, followed by BCS and SLNB one week later.
- Comparison with a control group undergoing palpation-guided BCS, using propensity score matching analysis.
Main Results:
- MWA guidance group showed a significantly lower rate of positive/close margins compared to the control group (P=0.018).
- MWA resulted in a higher rate of accurate surgery, defined by margin size (P=0.042).
- Sentinel lymph nodes were successfully identified in all eligible MWA cases, with no recurrence observed during a mean follow-up of 23 months.
Conclusions:
- Preoperative MWA can accurately guide BCS for T1/T2 breast cancer.
- MWA does not appear to impair the success of sentinel lymph node biopsy.
- Further clinical trials are needed to validate MWA for breast cancer excision guidance with long-term follow-up.

